Q2 2016 Earnings Previews
Q2 2016 Earnings Previews
$3,000.00
Datamonitor Healthcare previews Q2 2016 earnings for companies in the PharmaVitae portfolio. Companies will be continuously added the day before presentations.
Publisher: Datamonitor Healthcare
- Description
- Contents
- Samples
Datamonitor Healthcare previews Q2 2016 earnings for companies in the PharmaVitae portfolio. Companies will be continuously added the day before presentations.
Big Pharma
Novo Nordisk – 05/08/2016 (NEW)
Teva – 04/08/2016
Pfizer – 02/08/2016
Merck & Co – 29/07/2016
Sanofi – 29/07/2016
AbbVie – 29/07/2016
Bristol-Myers Squibb – 28/07/2016
AstraZeneca – 28/07/2016
Amgen – 2707/2016
Bayer – 27/07/2016
GlaxoSmithKline – 27/07/2016
Eli Lilly – 26/07/2016
Roche – 21/07/2016
Mid Pharma
Merck – 04/08/2016
Shire – 02/08/2016
Astellas – 29/07/2016
Gilead – 25/07/2016
Actelion – 21/07/2016
Biogen – 21/07/2016
Table of Contents
4 BIG PHARMA
4 Novo Nordisk [05/08/2016]
4 Teva [04/08/2016]
5 Pfizer [02/08/2016]
5 Merck [29/07/2016]
6 Sanofi [29/07/2016]
6 AbbVie [29/07/2016]
7 Bristol-Myers Squibb [28/07/2016]
7 AstraZeneca [28/07/2016]
8 Amgen [27/07/2016]
9 Bayer [27/07/2016]
9 GlaxoSmithKline [27/07/2016]
10 Eli Lilly [26/07/2016]
10 Roche [21/07/2016]
12 MID PHARMA
12 Merck KGaA [04/08/2016]
12 Biogen [21/07/2016]
12 Actelion [21/07/2016]
13 Gilead [25/07/2016]
13 Astellas [29/07/2016]
14 Shire [02/08/2016]
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Orphan Drug Market Outlook to 2017 
Sign up to the